Pharmadrug Inc - ESG Rating & Company Profile powered by AI
Scroll down to the bottom of this webpage for potential risks for Pharmadrug Inc based on industry, location and marketcap. This webpage contains a Q&A table for Pharmadrug Inc. Comprehensive Sustainability assessment of Pharmadrug Inc can be reached by registering for free.
Pharmadrug Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.9; made up of an environmental score of 4.0, social score of 5.3 and governance score of 5.3.
4.9
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
744 | Sopharma AD | 5.0 | High |
744 | vTv Therapeutics Inc | 5.0 | High |
764 | Pharmadrug Inc | 4.9 | High |
764 | BetterLife Pharma Inc | 4.9 | High |
764 | Acerus Pharmaceuticals Corporation | 4.9 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Pharmadrug Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Pharmadrug Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Pharmadrug Inc report the average age of the workforce?
Sign up for free to unlockDoes Pharmadrug Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Pharmadrug Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Pharmadrug Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Pharmadrug Inc offer flexible work?
Sign up for free to unlockDoes Pharmadrug Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Pharmadrug Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Pharmadrug Inc conduct supply chain audits?
Sign up for free to unlockDoes Pharmadrug Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Pharmadrug Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Pharmadrug Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Pharmadrug Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Pharmadrug Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Pharmadrug Inc disclose water use targets?
Sign up for free to unlockDoes Pharmadrug Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Pharmadrug Inc have a product recall in the last two years?
Sign up for free to unlockDoes Pharmadrug Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Pharmadrug Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Pharmadrug Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Pharmadrug Inc disclose parental leave metrics?
Sign up for free to unlockDoes Pharmadrug Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Pharmadrug Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Pharmadrug Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Pharmadrug Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Pharmadrug Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Pharmadrug Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Pharmadrug Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Pharmadrug Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Pharmadrug Inc disclose its waste policy?
Sign up for free to unlockDoes Pharmadrug Inc report according to TCFD requirements?
Sign up for free to unlockDoes Pharmadrug Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Pharmadrug Inc disclose energy use targets?
Sign up for free to unlockDoes Pharmadrug Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Pharmadrug Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Pharmadrug Inc
These potential risks are based on the size, segment and geographies of the company.
Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally-derived approved drugs. It also imports and distributes medical cannabis to pharmacies in Germany and rest of the European Union; and owns and operates Super Smart, an entity building to elevate the use of functional mushrooms and psilocybin mushrooms. In addition, the company engages in the researching and reformulating established natural medicines. It has a research agreement with the University of Michigan to evaluate N, N-dimethyltryptamine's (DMT) potential role in normal, diseased, and altered states of consciousness, as well as an agreement with Southwest Research Institute for initiating non-clinical and clinical manufacturing of cepharanthine; and clinical trial agreement with Johns Hopkins University to conduct a clinical study comparing acute and enduring psychological and neural effects of DMT and an undisclosed potently active comparator molecule. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. The company is based in Toronto, Canada.